Kobe, Japan

Dai Otagiri

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Healios K.k., Sumitomo Pharma Co., Ltd.. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dai Otagiri. Retrieved from https://idiyas.com/inventor/dai-otagiri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Location History:

  • Kobe, JP (2022)
  • Hyogo, JP (2023)

Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dai Otagiri: Innovator in Cellular Medicine

Introduction

Dai Otagiri is a notable inventor based in Kobe, Japan, recognized for his contributions to the field of cellular medicine. With a total of two patents to his name, Otagiri has made significant strides in developing innovative methods for transferring cellular medicine.

Latest Patents

Otagiri's latest patents include a method for transferring cellular medicine using a cellular medicine transfer system. This system features an adapter for a cellular medicine container, which includes a first flow channel and a second flow channel for the flow of liquid and cells. The system also comprises a cellular medicine container, an administration medium storage container, a collection container, and a powering device that facilitates the transfer of both the administration medium and the cellular medicine. Another significant patent involves a transplantation medium that enhances the post-thawing survival rate of cryopreserved retinal pigment epithelial (RPE) cells. This medium, which is pharmaceutically acceptable as an ocular irrigating solution and contains a poloxamer, improves the protection of photoreceptor cells during transplantation.

Career Highlights

Throughout his career, Dai Otagiri has worked with prominent companies such as Healios K.K. and Sumitomo Pharma Co., Ltd. His work in these organizations has contributed to advancements in medical technology and cellular therapies.

Collaborations

Otagiri has collaborated with esteemed colleagues, including Masakazu Inamori and Tadao Maeda. These partnerships have fostered innovation and development in the field of cellular medicine.

Conclusion

Dai Otagiri's innovative work in cellular medicine and his patents reflect his commitment to advancing medical technology. His contributions are paving the way for future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…